Catheter Precision, Inc. (VTAK)

USD 0.33

(-3.84%)

Market Cap (In USD)

2.62 Million

Revenue (In USD)

442 Thousand

Net Income (In USD)

-70.57 Million

Avg. Volume

205.59 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.31-8.4
PE
-
EPS
-
Beta Value
0.0
ISIN
US74933X3026
CUSIP
-
CIK
1716621
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. David A. Jenkins
Employee Count
-
Website
https://www.catheterprecision.com
Ipo Date
2018-09-27
Details
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.